Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in CRISPR THERAPEUTICS AG
BNP PARIBAS FINANCIAL MARKETS holds 26,987 shares of CRSP (CRISPR THERAPEUTICS AG), worth $1.4M as of 2025-Q4. The position was increased (++7.8% shares). CRSP represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.4M
Current Shares
26,987
Total Value Change
-$5.9M
Total Shares Change
-109,346
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Increased |
| 26,987 |
+7.8% |
| $1.4M |
| 0.0% |
| $53.19 |
28 |
| 2025-Q3 | Increased | 25,026 | +30.0% | $1.6M | 0.0% | $63.77 | 32 |
| 2025-Q2 | Increased | 19,257 | +4.6% | $936,660 | 0.0% | $47.49 | 26 |
| 2025-Q1 | Decreased | 18,415 | -77.8% | $626,662 | 0.0% | $36.99 | 0 |
| 2024-Q4 | Decreased | 82,994 | -5.6% | $3.3M | 0.0% | $38.65 | 0 |
| 2024-Q3 | Decreased | 87,956 | -35.5% | $4.1M | 0.0% | $47.32 | 0 |
| 2024-Q2 | Decreased | 136,333 | -8.5% | $7.4M | 0.0% | $54.01 | 0 |